A glucose panel groups the blood tests that show how your body handles sugar — from a single fasting glucose to HbA1c, which averages the last three months, alongside insulin-based measures. Read together they classify normal, prediabetes and diabetes, and show whether the problem is too little insulin or resistance to it.
What the glucose panel measures
The panel answers two separate questions. The first is how high is the sugar — captured as a snapshot by glucose, as a three-month average by HbA1c, as a two-to-three-week average by fructosamine, and as a dynamic response by the glucose tolerance test. The second is why — answered by the insulin side: insulin, C-peptide and the HOMA-IR index.
Because each test covers a different time window — minutes for glucose, two to three weeks for fructosamine, three months for HbA1c — they cross-check one another whenever a single result is thrown off by illness or an unusual meal.
Reading them together is also what separates the two main types of diabetes. High sugar with high insulin is a resistance pattern; high sugar with low insulin is a deficiency pattern. One number alone cannot tell them apart.
Which tests are included
- Glucose — blood sugar right now; usually measured fasting.
- HbA1c — the three-month sugar average; the main test for diagnosis and monitoring.
- Insulin — the hormone that lowers sugar; high when the body is resistant.
- C-peptide — shows how much insulin the pancreas is making itself.
- HOMA-IR — an index combining fasting glucose and insulin to estimate resistance.
- Glucose tolerance test — sugar measured before and after a glucose drink.
- Fructosamine — a two-to-three-week average, used when HbA1c is unreliable.
Glucose is reported in mg/dL in the US and mmol/L in most other countries; a unit converter moves between them so a result reads the same on any report.
When doctors order it
The panel is used to screen for diabetes at a checkup, especially with excess weight, high blood pressure or a family history, and to investigate symptoms such as excessive thirst, frequent urination, unexplained fatigue or blurred vision. A glucose tolerance test is standard in pregnancy to check for gestational diabetes, and the whole panel is used to monitor people already living with diabetes. In children and young adults, sudden thirst, weight loss and fatigue can signal fast-developing type 1 diabetes and prompt urgent testing. Suspected low blood sugar is investigated the same way.
How to prepare
Preparation depends on which tests are ordered. Fasting glucose, fasting insulin and HOMA-IR need 8 to 12 hours without food, though water is encouraged. HbA1c and fructosamine need no fasting. The glucose tolerance test starts fasting and then measures your response to a standard sugar drink. Avoid unusual carbohydrate loading or intense exercise the day before, and tell the lab about any medication.
How to read the results together
By widely used guideline cutoffs, a fasting glucose of 100–125 mg/dL (5.6–6.9 mmol/L) or an HbA1c of 5.7–6.4% marks prediabetes, while a fasting glucose of 126 mg/dL (7.0 mmol/L) or more, or an HbA1c of 6.5% or more, marks diabetes — each confirmed on a second test.
- Both averages high. A high fasting glucose and a high HbA1c together indicate sustained high sugar, landing in the diabetes range when both clear the cutoff.
- Resistance versus deficiency. High glucose with high insulin or HOMA-IR points to insulin resistance, the type 2 pattern; high glucose with low C-peptide points to insulin deficiency, the type 1 pattern.
- Hidden early change. A normal HbA1c with a high two-hour glucose tolerance test can reveal impaired tolerance before the average sugar rises.
- Low-sugar work-up. When the question is unexplained low blood sugar, insulin and C-peptide are measured during an episode to show whether the body is making too much of its own insulin.
When to retest
A first abnormal result is confirmed on a second sample before any diagnosis is made. Prediabetes is usually followed with an HbA1c about once a year, alongside lifestyle changes. Established diabetes is monitored with an HbA1c every three to six months, more often when treatment is changing. Read your numbers against your own lab’s range, and let the doctor who ordered the panel set your retesting schedule.
